Top

Published in:

01-01-2019 | Original Article

TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression

Authors: Maya Gershkovitz, Tanya Fainsod-Levi, Tamir Zelter, Ronit V. Sionov, Zvi Granot

Published in: Cancer Immunology, Immunotherapy | Issue 1/2019

Abstract

In recent years, immune cells were shown to play critical roles in tumor growth and metastatic progression. In this context, neutrophils were shown to possess both pro- and anti-tumor properties. To exert their anti-tumor effect, neutrophils need to migrate towards, and form physical contact with tumor cells. Neutrophils secrete H₂O₂ in a contact-dependent mechanism, thereby inducing a lethal Ca²⁺ influx via the activation of the H₂O₂-dependent TRPM2 Ca²⁺ channel. Here, we explored the mechanism regulating neutrophil chemoattraction to tumor cells. Interestingly, we found that TRPM2 plays a role in this context as well, since it regulates the expression of potent neutrophil chemoattractants. Consequently, cells expressing reduced levels of TRPM2 are not approached by neutrophils. Together, these observations demonstrate how tumor cells expressing reduced levels of TRPM2 evade neutrophil cytotoxicity in two interrelated mechanisms—downregulation of neutrophil chemoattractants and blocking of the apoptotic Ca²⁺-dependent cascade. These observations demonstrate a critical role for TRPM2 in neutrophil-mediated immunosurveillance and identify cells expressing low levels of TRPM2, as a potential target for cancer therapy.

Available only for authorised users

Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14(10):1014–1022. https://doi.org/10.1038/ni.2703 CrossRefPubMedPubMedCentral

Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13(3):159–175. https://doi.org/10.1038/nri3399 CrossRefPubMed

Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S (2013) Tumor associated macrophages and neutrophils in cancer. Immunobiology 218(11):1402–1410. https://doi.org/10.1016/j.imbio.2013.06.003 CrossRefPubMed

Galli SJ, Borregaard N, Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12(11):1035–1044. https://doi.org/10.1038/ni.2109 CrossRefPubMedPubMedCentral

Nozawa H, Chiu C, Hanahan D (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103(33):12493–12498CrossRefPubMedPubMedCentral

De Larco JE, Wuertz BR, Furcht LT (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 10(15):4895–4900CrossRefPubMed

Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels L, Jonkers J, de Visser KE (2015) IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522(7556):345–348. https://doi.org/10.1038/nature14282 CrossRefPubMedPubMedCentral

Moses K, Brandau S (2016) Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. Semin Immunol 28(2):187–196. https://doi.org/10.1016/j.smim.2016.03.018 CrossRefPubMed

Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, Lee K (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58(1):15–23. https://doi.org/10.1007/s00262-008-0516-3 CrossRefPubMed

10.

Faget J, Groeneveld S, Boivin G, Sankar M, Zangger N, Garcia M, Guex N, Zlobec I, Steiner L, Piersigilli A, Xenarios I, Meylan E (2017) Neutrophils and snail orchestrate the establishment of a pro-tumor microenvironment in lung cancer. Cell Rep 21(11):3190–3204. https://doi.org/10.1016/j.celrep.2017.11.052 CrossRefPubMed

11.

Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos SA, Courties G, Rickelt S, Severe N, Baryawno N, Faget J, Savova V, Zemmour D, Kline J, Siwicki M, Garris C, Pucci F, Liao HW, Lin YJ, Newton A, Yaghi OK, Iwamoto Y, Tricot B, Wojtkiewicz GR, Nahrendorf M, Cortez-Retamozo V, Meylan E, Hynes RO, Demay M, Klein A, Bredella MA, Scadden DT, Weissleder R, Pittet MJ (2017) Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF(high) neutrophils. Science. https://doi.org/10.1126/science.aal5081 CrossRefPubMedPubMedCentral

12.

Michaeli J, Shaul ME, Mishalian I, Hovav AH, Levy L, Zolotriov L, Granot Z, Fridlender ZG (2017) Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFalpha and NO-dependent mechanism, promoting a tumor-supportive environment. Oncoimmunology 6(11):e1356965. https://doi.org/10.1080/2162402X.2017.1356965 CrossRefPubMedPubMedCentral

13.

Chao T, Furth EE, Vonderheide RH (2016) CXCR2-dependent accumulation of tumor-associated neutrophils regulates T-cell immunity in pancreatic ductal adenocarcinoma. Cancer Immunol Res 4(11):968–982. https://doi.org/10.1158/2326-6066.CIR-16-0188 CrossRefPubMedPubMedCentral

14.

Wculek SK, Malanchi I (2015) Neutrophils support lung colonization of metastasis-initiating breast cancer cells. Nature 528(7582):413–417. https://doi.org/10.1038/nature16140 CrossRefPubMedPubMedCentral

15.

Donati K, Sepult C, Rocks N, Blacher S, Gerard C, Noel A, Cataldo D (2017) Neutrophil-derived interleukin 16 in premetastatic lungs promotes breast tumor cell seeding. Cancer Growth Metast 10:1179064417738513. https://doi.org/10.1177/1179064417738513 CrossRef

16.

Colombo MP, Lombardi L, Stoppacciaro A, Melani C, Parenza M, Bottazzi B, Parmiani G (1992) Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. J Immunol 149(1):113–119PubMed

17.

Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R (2011) Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20(3):300–314. https://doi.org/10.1016/j.ccr.2011.08.012 CrossRefPubMedPubMedCentral

18.

Lopez-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RS (2013) Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32(14):1752–1760. https://doi.org/10.1038/onc.2012.201 CrossRefPubMed

19.

Finisguerra V, Di Conza G, Di Matteo M, Serneels J, Costa S, Thompson AA, Wauters E, Walmsley S, Prenen H, Granot Z, Casazza A, Mazzone M (2015) MET is required for the recruitment of anti-tumoural neutrophils. Nature 522(7556):349–353. https://doi.org/10.1038/nature14407 CrossRefPubMedPubMedCentral

20.

Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, Damti P, Lumbroso D, Polyansky L, Sionov RV, Ariel A, Hovav AH, Henke E, Fridlender ZG, Granot Z (2015) Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep 10(4):562–573. https://doi.org/10.1016/j.celrep.2014.12.039 CrossRefPubMed

21.

Gershkovitz M, Caspi Y, Fainsod-Levi T, Katz B, Michaeli J, Khawaled S, Lev S, Polyansky L, Shaul ME, Sionov RV, Cohen-Daniel L, Aqeilan RI, Shaul YD, Mori Y, Karni R, Fridlender ZG, Binshtok AM, Granot Z (2018) TRPM2 mediates neutrophil killing of disseminated tumor cells. Cancer Res 78(10):2680–2690. https://doi.org/10.1158/0008-5472.CAN-17-3614 CrossRefPubMed

22.

Gershkovitz M, Fainsod-Levi T, Khawaled S, Shaul ME, Sionov RV, Cohen-Daniel L, Aqeilan RI, Shaul Y, Fridlender ZG, Granot Z (2018) Microenvironmental cues determine tumor cell susceptibility to neutrophil cytotoxicity. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-18-0540 CrossRefPubMed

23.

Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, Yamada H, Shimizu S, Mori E, Kudoh J, Shimizu N, Kurose H, Okada Y, Imoto K, Mori Y (2002) LTRPC2 Ca²⁺-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell 9(1):163–173CrossRefPubMed

24.

Montell C, Birnbaumer L, Flockerzi V (2002) The TRP channels, a remarkably functional family. Cell 108(5):595–598CrossRefPubMed

25.

Zeng X, Sikka SC, Huang L, Sun C, Xu C, Jia D, Abdel-Mageed AB, Pottle JE, Taylor JT, Li M (2010) Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis 13(2):195–201. https://doi.org/10.1038/pcan.2009.55 CrossRefPubMed

26.

Knowles H, Li Y, Perraud AL (2013) The TRPM2 ion channel, an oxidative stress and metabolic sensor regulating innate immunity and inflammation. Immunol Res 55(1–3):241–248. https://doi.org/10.1007/s12026-012-8373-8 CrossRefPubMed

27.

Syed Mortadza SA, Wang L, Li D, Jiang LH (2015) TRPM2 channel-mediated ROS-sensitive Ca(2+) signaling mechanisms in immune cells. Front Immunol 6:407. https://doi.org/10.3389/fimmu.2015.00407 CrossRefPubMedPubMedCentral

28.

Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y, Negoro T, Hiroi T, Kiuchi Y, Okada T, Kaneko S, Lange I, Fleig A, Penner R, Nishi M, Takeshima H, Mori Y (2008) TRPM2-mediated Ca²⁺ influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med 14(7):738–747. https://doi.org/10.1038/nm1758 CrossRefPubMedPubMedCentral

29.

Mittal M, Nepal S, Tsukasaki Y, Hecquet CM, Soni D, Rehman J, Tiruppathi C, Malik AB (2017) Neutrophil activation of endothelial cell-expressed TRPM2 mediates transendothelial neutrophil migration and vascular injury. Circ Res 121(9):1081–1091. https://doi.org/10.1161/CIRCRESAHA.117.311747 CrossRefPubMedPubMedCentral

30.

Jablonska J, Wu CF, Andzinski L, Leschner S, Weiss S (2014) CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFN-beta. Int J Cancer 134(6):1346–1358. https://doi.org/10.1002/ijc.28551 CrossRefPubMed

31.

Yu PF, Huang Y, Han YY, Lin LY, Sun WH, Rabson AB, Wang Y, Shi YF (2017) TNFalpha-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2(+) neutrophils. Oncogene 36(4):482–490. https://doi.org/10.1038/onc.2016.217 CrossRefPubMed

32.

Miller BA (2006) The role of TRP channels in oxidative stress-induced cell death. J Membr Biol 209(1):31–41. https://doi.org/10.1007/s00232-005-0839-3 CrossRefPubMed

33.

Sionov RV, Assi S, Gershkovitz M, Sagiv JY, Polyansky L, Mishalian I, Fridlender ZG, Granot Z (2015) Isolation and characterization of neutrophils with anti-tumor properties. J Vis Exp 100:e52933. https://doi.org/10.3791/52933 CrossRef

34.

Powell DR, Huttenlocher A (2016) Neutrophils in the tumor microenvironment. Trends Immunol 37(1):41–52. https://doi.org/10.1016/j.it.2015.11.008 CrossRefPubMed

35.

Fridlender ZG, Albelda SM (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis 33(5):949–955. https://doi.org/10.1093/carcin/bgs123 CrossRefPubMed

36.

Jablonska J, Granot Z (2017) Neutrophil, quo vadis? J Leukoc Biol 102(3):685–688. https://doi.org/10.1189/jlb.3MR0117-015R CrossRefPubMed

37.

Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16(3):183–194. https://doi.org/10.1016/j.ccr.2009.06.017 CrossRefPubMedPubMedCentral

38.

Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120(4):1151–1164. https://doi.org/10.1172/JCI37223 CrossRefPubMedPubMedCentral

39.

Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25(3):387–408. https://doi.org/10.1007/s10555-006-9004-4 CrossRefPubMed

40.

Nagarsheth N, Wicha MS, Zou W (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17(9):559–572. https://doi.org/10.1038/nri.2017.49 CrossRefPubMedPubMedCentral

41.

Caetano MS, Zhang H, Cumpian AM, Gong L, Unver N, Ostrin EJ, Daliri S, Chang SH, Ochoa CE, Hanash S, Behrens C, Wistuba II, Sternberg C, Kadara H, Ferreira CG, Watowich SS, Moghaddam SJ (2016) IL6 blockade reprograms the lung tumor microenvironment to limit the development and progression of K-ras-mutant lung cancer. Cancer Res 76(11):3189–3199. https://doi.org/10.1158/0008-5472.CAN-15-2840 CrossRefPubMedPubMedCentral

42.

Sionov RV, Fridlender ZG, Granot Z (2015) The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron 8(3):125–158. https://doi.org/10.1007/s12307-014-0147-5 CrossRefPubMed

Title: TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression
Authors: Maya Gershkovitz
Tanya Fainsod-Levi
Tamir Zelter
Ronit V. Sionov
Zvi Granot
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: Cancer Immunology, Immunotherapy / Issue 1/2019
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-018-2249-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter

An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells

CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer

The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer